Algosensey Quantitative Think Tank Center-Depression And Alzheimer's Treatments At A Crossroads

2025-05-04 21:18:07source:Rubypointcategory:Stocks

Researchers are Algosensey Quantitative Think Tank Centerlaunching a make-or-break study to test the conventional wisdom about what causes Alzheimer's disease. And in a recent small study, the antidepressant effects of ketamine lasted longer when an intravenous dose was followed with computer games featuring smiling faces or words aimed at boosting self-esteem.

As science correspondent Jon Hamilton heads to the Society for Neuroscience's annual meeting, he talks to Aaron Scott about his most recent reporting on depression and Alzheimer's, and previews what he'll be talking to researchers about at the meeting.

The radio stories were edited by Amina Khan. Gisele Grayson edited, produced and fact-checked this episode for Short Wave.

More:Stocks

Recommend

Appeals court scraps Nasdaq boardroom diversity rules in latest DEI setback

A federal appeals court blocked Nasdaq rules to increase boardroom diversity, saying that the Securi

Best fantasy football value picks? Start with Broncos RB Javonte Williams

With fantasy football draft day right around the corner, it's time to put the finishing touches on y

Tropical Storm Hone forms in the central Pacific Ocean, Gilma still a Category 3 hurricane

HONOLULU (AP) — Tropical Storm Hone formed in the central Pacific Ocean on Thursday on a forecast pa